LCMS
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.
Pořadatel
Waters Corporation
Waters Corporation
Firmu Waters založil v roce 1958 pan James Waters. Od té doby se společnost Waters specializuje na kapalinovou chromatografii a hmotnostní spektrometrii. Divize TA Instruments působí na poli termální analýzy. V České republice je Waters zastoupen přímou pobočkou, která sídlí v Praze.
Tagy
GPC/SEC
LinkedIn Logo

Beyond Surface Separation: Navigating Mega Molecule Sizing with Wide Pore SEC-MALS

ZÁZNAM | Proběhlo St, 20.5.2026
Zjistěte, jak struktura pórů ovlivňuje separaci velkých biomolekul metodou SEC. Seznamte se s tím, jak metoda SEC-MALS umožňuje přesné stanovení velikosti, analýzu agregace a spolehlivý vývoj metod.
Přejít na webinář
Waters Corporation: Upcoming events
Waters Corporation: Upcoming events

Better SEC Methods Begin with Understanding Pore Structure

Characterizing large biomolecules like viral vectors, plasmids, and LNPs remains a major analytical challenge due to their size, heterogeneity, and sensitivity to method conditions. Wide- and ultra-wide-pore SEC enables size-based separation, but understanding pore accessibility and true analyte behavior requires deeper insight.

In this webinar, we combine advanced SEC pore characterization with multi-angle light scattering (MALS) detection to reveal how pore structure, accessibility, and distribution impact separation performance. Learn how dual-probe approaches and SEC-MALS workflows enable accurate sizing, aggregation analysis, and robust method development for genetic medicine applications.

What you will learn:

  • Understand how pore size distribution impacts SEC selectivity and resolution
  • Learn differences between structural vs. chromatographic pore characterization
  • Apply SEC-MALS for accurate size and molar mass of large biomolecules
  • Identify optimal wide-pore SEC conditions for viral vectors, LNPs, and plasmids
  • Translate pore accessibility into better method development decisions

Who should attend

Biopharma analytical development scientists, Gene therapy and Genetic medicine researchers (AAV, mRNA, LNPs), QC and CMC scientists, Chromatography and biophysical characterization specialists, Lab managers and directors in biologics and advanced therapies.

Speaker: Szabolcs Fekete PhD (Consulting Scientist, Genetic Medicine, Waters Corporation)

Szabolcs worked in the pharmaceutical industry for 10 years before joining the University of Geneva Deparment of Pharmaceutical Sciences. In 2021, he joined Waters Corporation and now works as a Consulting Scientist. He contributed to ~190 peer-reviewed journal articles and co-authored 10+ book chapters and co-edited handbooks. ​

His current interests include separations of new chemical modalities, fundamentals of chromatography, column technology, and method development approaches and modeling. ​

He was the winner of the LCGC Emerging Leader in Chromatography Award in 2020 and the HTC Innovation Award in 2022

Waters Corporation
LinkedIn Logo
 

Mohlo by Vás zajímat

Benefits of Agilent Altura Ultra Inert HPLC Column Hardware

Aplikace
| 2026 | Agilent Technologies
Instrumentace
Spotřební materiál, LC kolony
Výrobce
Agilent Technologies
Zaměření
Životní prostředí

Vinylene carbonate water determination via coulometric Karl Fischer titration

Aplikace
| 2026 | Metrohm
Instrumentace
Titrace Karl Fischer, Voltametrie/Coulometrie
Výrobce
Metrohm
Zaměření
Polovodiče

An Isocratic Separation of B Vitamins Using Waters XBridge Biphenyl RP Column with MaxPeak Premier Technology

Aplikace
| 2026 | Waters
Instrumentace
Spotřební materiál, LC kolony
Výrobce
Waters
Zaměření
Farmaceutická analýza

Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System

Postery
| 2026 | Agilent Technologies (ASMS)
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza

Increased sensitivity for low-input label-free proteomics using the Orbitrap Astral MS and μPAC Neo Plus Columns

Aplikace
| 2026 | Thermo Fisher Scientific
Instrumentace
LC/HRMS, LC/Orbitrap, LC/MS, LC/MS/MS
Výrobce
Thermo Fisher Scientific
Zaměření
Proteomika
Další projekty
GCMS
ICPMS
Sledujte nás
FacebookX (Twitter)LinkedInYouTube
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.